MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.

about

MF59-adjuvanted influenza vaccine (FLUAD®) elicits higher immune responses than a non-adjuvanted influenza vaccine (Fluzone®): A randomized, multicenter, Phase III pediatric trial in Mexico.

Item

http://www.wikidata.org/entity/Q50024815

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@en

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@nl

type

Item

label

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@en

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@nl

prefLabel

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@en

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@nl

P1476

MF59-adjuvanted influenza vacc ...... III pediatric trial in Mexico.

@en

P2093

Ashwani Kumar Arora

http://www.w3.org/2001/XMLSchema#string

Aurelio Cruz-Valdez

http://www.w3.org/2001/XMLSchema#string

Esther Heijnen

http://www.w3.org/2001/XMLSchema#string

Flavia V Castelli

http://www.w3.org/2001/XMLSchema#string

Gabriel Valdez-Zapata

http://www.w3.org/2001/XMLSchema#string

Marcia G Garcia

http://www.w3.org/2001/XMLSchema#string

Sanjay S Patel

http://www.w3.org/2001/XMLSchema#string

Wim T Jansen

http://www.w3.org/2001/XMLSchema#string

P2860

Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.

Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.

Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study.

A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.

Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion.

P304

386-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21645515.2017.1373227

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28925801

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial

P932

5806633

http://www.w3.org/2001/XMLSchema#string